The brain penetrant PPARγ agonist leriglitazone restores multiple altered pathways in models of X-linked adrenoleukodystrophy

渗透剂(生化) 肾上腺脑白质营养不良 内分泌学 内科学 神经科学 医学 药理学 受体 兴奋剂 生物 化学 过氧化物酶体 有机化学
作者
Laura Rodríguez‐Pascau,Anna Vilalta,M Cerrada,Estefania Traver,Sonja Forss‐Petter,Isabelle Weinhofer,Jan Bauer,Stephan Kemp,Guillem Pina,Sílvia Pascual,Uwe Meya,Patricia Leonor Musolino,Johannes Berger,Marc Martinell,Pilar M. Pizcueta
出处
期刊:Science Translational Medicine [American Association for the Advancement of Science]
卷期号:13 (596) 被引量:42
标识
DOI:10.1126/scitranslmed.abc0555
摘要

X-linked adrenoleukodystrophy (X-ALD), a potentially fatal neurometabolic disorder with no effective pharmacological treatment, is characterized by clinical manifestations ranging from progressive spinal cord axonopathy [adrenomyeloneuropathy (AMN)] to severe demyelination and neuroinflammation (cerebral ALD-cALD), for which molecular mechanisms are not well known. Leriglitazone is a recently developed brain penetrant full PPARγ agonist that could modulate multiple biological pathways relevant for neuroinflammatory and neurodegenerative diseases, and particularly for X-ALD. We found that leriglitazone decreased oxidative stress, increased adenosine 5'-triphosphate concentration, and exerted neuroprotective effects in primary rodent neurons and astrocytes after very long chain fatty acid-induced toxicity simulating X-ALD. In addition, leriglitazone improved motor function; restored markers of oxidative stress, mitochondrial function, and inflammation in spinal cord tissues from AMN mouse models; and decreased the neurological disability in the EAE neuroinflammatory mouse model. X-ALD monocyte-derived patient macrophages treated with leriglitazone were less skewed toward an inflammatory phenotype, and the adhesion of human X-ALD monocytes to brain endothelial cells decreased after treatment, suggesting the potential of leriglitazone to prevent the progression to pathologically disrupted blood-brain barrier. Leriglitazone increased myelin debris clearance in vitro and increased myelination and oligodendrocyte survival in demyelination-remyelination in vivo models, thus promoting remyelination. Last, leriglitazone was clinically tested in a phase 1 study showing central nervous system target engagement (adiponectin increase) and changes on inflammatory biomarkers in plasma and cerebrospinal fluid. The results of our study support the use of leriglitazone in X-ALD and, more generally, in other neuroinflammatory and neurodegenerative conditions.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
岩浆果冻完成签到,获得积分10
刚刚
1秒前
夏酥完成签到,获得积分10
1秒前
John完成签到,获得积分10
1秒前
joysa完成签到,获得积分10
1秒前
2秒前
2秒前
修好世界完成签到,获得积分10
2秒前
Monkey完成签到,获得积分10
2秒前
zpctx完成签到,获得积分10
2秒前
2秒前
2秒前
2秒前
StuXuhao完成签到,获得积分10
2秒前
frank完成签到,获得积分10
2秒前
火星上含芙完成签到,获得积分10
3秒前
3秒前
AeAeAe完成签到,获得积分10
3秒前
唠叨的白曼完成签到,获得积分10
3秒前
Xinyi完成签到,获得积分10
3秒前
wanci的应助被全都一次过采纳,获得30
4秒前
walkerwan完成签到,获得积分10
4秒前
香蕉觅云的应助被123采纳,获得10
4秒前
传奇3的应助被123采纳,获得10
4秒前
顾矜的应助被小豪采纳,获得10
4秒前
4秒前
xiaofan1991完成签到,获得积分10
5秒前
灵巧宛亦发布了新的文献求助10
5秒前
5秒前
浩如烟海完成签到,获得积分10
5秒前
李健的小迷弟的应助被cc采纳,获得10
6秒前
辛勤月饼完成签到,获得积分10
6秒前
敲罗打鼓发布了新的文献求助10
6秒前
GG完成签到,获得积分10
6秒前
我是猫完成签到,获得积分10
6秒前
cole完成签到,获得积分10
6秒前
su完成签到,获得积分10
6秒前
123发布了新的文献求助10
7秒前
msk发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8159542
求助须知:如何正确求助?哪些是违规求助? 9555044
关于积分的说明 21724263
捐赠科研通 7749434
什么是DOI,文献DOI怎么找? 3427246
关于科研通互助平台的介绍 2552263
邀请新用户注册赠送积分活动 2471618